The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Entrada Therapeutics(NASDAQ:TRDA) 
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, wh...
Share this website to your friends
Entrada Therapeutics Days Payable Outstanding ttm (DPO)
Entrada Therapeutics Days Receivable Outstanding ttm (DSO)
Entrada Therapeutics Days Inventory Outstanding ttm (DIO)
Entrada Therapeutics Op Cashflow Per Share ttm
Entrada Therapeutics Free Cashflow Per Share ttm
Entrada Therapeutics Cash Per Share ttm
Entrada Therapeutics P/S ratio ttm
Entrada Therapeutics (GAAP) P/E ratio ttm
Entrada Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.